Premarket Movers | Grab Jumps over 5%; Lattice Semiconductor Rockets 9%; Fabrinet Surges 10%; Harmonic Soars 14%; Aehr Test Pops 15%

Tiger Newspress
昨天

Grab Holdings rose 5.6% in premarket trading. The move followed the company’s latest quarterly results, with Q3 sales reported at $1.112 billion, above the $1.073 billion estimate and also ahead of a separate $1.05 billion consensus figure.

Lattice Semiconductor rose 8.86% in Pre-Market Trading. The move followed a fiscal third-quarter report that beat market expectations on both profit and revenue, alongside fourth-quarter guidance that also came in above consensus.

For the quarter ended October 3, non-GAAP EPS was $0.72, up from $0.28 a year earlier and above the $0.55 consensus, while revenue rose to $291 million from $133.3 million, topping the $255.9 million expectation.

Fabrinet rose 10.45% premarket. The move followed a quarterly report that beat market expectations and a second-quarter outlook that came in well above consensus. Fabrinet reported first-quarter revenue of $1.47 billion, a record high, exceeding the roughly $1.40 billion market expectation and rising 51% from $978.1 million a year earlier.

Harmonic stock jumped 14% premarket. The broadband solutions provider's Q3 revenue rose 64% yr/yr, beating analyst expectations. Adjusted EPS for Q3 beat analyst expectations. Company raised full-year 2026 revenue outlook.

Aehr Test rose 15.41% in Pre-Market Trading. The immediate catalyst was a fiscal first-quarter report that came in well above market expectations, alongside a higher full-year revenue outlook.

Aehr Test reported adjusted EPS of $0.28 versus the $0.11 consensus estimate, while revenue reached $33.007 million, above the expected $27.072 million. The company also said adjusted net income for the fiscal year is expected to be at least 20% of revenue, with backlog at $100.9 million as of September 25.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10